1800 Total Publications
Integrative genomics identifies APOE ε4 effectors in Alzheimer’s disease.
Rhinn, H., Fujita, R., Qiang, L., Cheng, R., Lee, J. H., & Abeliovich, A.
2013; Journal Nature; vol. 500; no. 7460; pp. 45-50;
AWUVFUjTMOwVf_qbJr8i
doi:10.1038/nature12415
Relationship between imaging biomarkers, age, progression and symptom severity in Alzheimer’s disease.
Dukart, J., Mueller, K., Villringer, A., Kherif, F., Draganski, B., Frackowiak, R., & Schroeter, M. L.
2013; Journal Neuroimage: Clinical; vol. 3; pp. 84-94;
AWUVFUjTMOwVf_qbJr8n
doi:10.1016/j.nicl.2013.07.005
Effects of baseline CSF alpha-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer’s disease.
Mattsson, N., Insel, P., Tosun, D., Zhang, J., Jack Jr., C. R., Galasko, D., … Weiner, M.
2013; Journal PloS One; vol. 8; no. 12; pp. e85443;
AWUVFUjTMOwVf_qbJr8s
doi:10.1371/journal.pone.0085443
White Matter Abnormalities and Structural Hippocampal Disconnections in Amnestic Mild Cognitive Impairment and Alzheimer’s Disease.
Rowley, J., Fonov, V., Wu, O., Eskildsen, S. F., Schoemaker, D., Wu, L., … Rosa-Neto, P.
2013; Journal PloS One; vol. 8; no. 9; pp. 1-13;
AWUVFUjTMOwVf_qbJr8t
doi:10.1371/journal.pone.0074776
Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers.
Shaffer, J. L., Petrella, J. R., Sheldon, F. C., Choudhury, K. R., Calhoun, V. D., Coleman, R. E., & Doraiswamy, P. M.
2013; Journal Radiology; vol. 266; no. 2; pp. 583-591;
AWUVAA3tMOwVf_qbJr8D
doi:10.1148/radiol.12120010